Vendors often bring new products directly to trauma program leaders because they believe trauma has more sway over purchase decisions. However, even when the clinical need for a product is clear, many trauma leaders are unsure how to work with their Value Analysis Committee to secure approval.
This webinar demystifies the Value Analysis process and shows how trauma professionals can work efficiently and collaboratively with their hospital’s Value Analysis team.
Experienced trauma leader Melinda Case explains how to identify the full range of value offered by a new product and how to work with colleagues to verify clinical need. And Mark Copeland (the “Value Analysis Whisperer”) shows exactly how to frame new product requests for maximum clarity and present them effectively to your hospital’s Value Analysis Committee.
Click below to view the webinar recording on demand and download the presentation:
In this one-hour webinar, viewers will learn:
- How to identify the factors (beyond cost) that determine product value for patients and providers
- How to develop a Cost-Benefit Analysis for a new product and calculate its Return on Investment
- How to use an “executive business summary” to present a product to your Value Analysis Committee
In addition, Blake Havers from Aspen Medical Products presents a short case study that illustrates the concepts presented by Melinda and Mark. Focusing on the VRTX System, Aspen’s new off-the-shelf cervical-to-sacrum spine immobilizer, Blake demonstrates how to define total product value, quantify costs and benefits, and effectively communicate the findings.
This webinar is designed for anyone who has a stake in ensuring trauma patients receive high-quality, cost-effective care — trauma program managers, trauma medical directors and trauma staff, plus Value Analysis Committee members, supply chain managers and hospital executive leaders.